Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ESTUDIOS


09 noviembre 2015

CIRCULATION: CARDIOVASCULAR INTERVENTIONS. Efficacy of Ex Vivo Autologous and In Vivo Platelet Transfusion in the Reversal of P2Y12 Inhibition by Clopidogrel, Prasugrel, and Ticagrelor. The APTITUDE Study

Stephen A. O’Connor, Julien Amour, Anne Mercadier, Réjane Martin, Mathieu Kerneis, Jérémie Abtan, Delphine Brugier, Johanne Silvain, Olivier Barthélémy, Pascal Leprince, Gilles Montalescot, Jean-Philippe Collet and for the ACTION Study Group

Background: Allogenic platelet transfusions (PT) are administered to treat excessive bleeding in patients on P2Y12 receptor inhibitors (RI). We assessed the effect of ex vivo and in vivo PT on platelet activation and aggregation in patients on dual antiplatelet therapy.

28 octubre 2015

CIRCULATION: CARDIOVASCULAR INTERVENTIONS. Coronary Artery Fistulae

Gautam Reddy, James E. Davies, David R. Holmes, Hartzell V. Schaff, Satinder P. Singh, Oluseun O. Alli

Case Presentation: Two patients presented to our cardiology clinic. Mr. H was 70 years old with a history of cardiac transplantation for ischemic cardiomyopathy. He presented with worsening dyspnea. Two years ago, he could run up 2 flights of stairs but had recently started to become short of breath while walking short distances. He also described pedal edema and progressive orthopnea. His medical history was significant for coronary artery disease. On examination, we noted an elderly male (6′0″; 85 kg). The heart rate was 90 bpm with a blood pressure of 156/90 mm Hg. The SaO2 was 98% on room air. The heart sounds were normal, but we auscultated a III/VI continuous machinery murmur over the left upper sternal border. His ECG showed sinus rhythm and left ventricular hypertrophy. The chest radiograph displayed mild cardiomegaly. We performed a transthoracic echocardiogram that was remarkable for concentric left ventricular hypertrophy with normal ejection fractions. Right heart catheterization revealed normal filling pressures and cardiac output. An endomyocardial biopsy showed no evidence of allograft rejection.

07 octubre 2016

CIRCULATION: CARDIOVASCULAR INTERVENTIONS. Procedural and Long-Term Outcomes of Bioresorbable Scaffolds Versus Drug-Eluting Stents in Chronic Total Occlusions. The BONITO Registry (Bioresorbable Scaffolds Versus Drug-Eluting Stents in Chronic Total Occlusions)

Lorenzo Azzalini, Gennaro Giustino, Soledad Ojeda, Antonio Serra, Alessio La Manna, Hung Q. Ly, Barbara Bellini, Susanna Benincasa, Jorge Chavarría, Livia L. Gheorghe, Giovanni Longo, Eligio Miccichè, Guido D’Agosta, Fabien Picard, Manuel Pan, Corrado Tamburino, Azeem Latib, Mauro Carlino, Alaide Chieffo, Antonio Colombo

Background: There is little evidence regarding the efficacy and safety of bioresorbable scaffolds (BRS) for the percutaneous treatment of chronic total occlusions.

03 noviembre 2016

CIRCULATION: CARDIOVASCULAR INTERVENTIONS. Comparison Between 1- and 2-Stent Strategies in Unprotected Distal Left Main Disease. The Milan and New-Tokyo Registry

Kensuke Takagi, Toru Naganuma, Alaide Chieffo, Yusuke Fujino, Azeem Latib, Satoko Tahara, Hisaaki Ishiguro, Matteo Montorfano, Mauro Carlino, Hiroyoshi Kawamoto, Naoyuki Kurita, Koji Hozawa, Shotaro Nakamura, Sunao Nakamura, Antonio Colombo

Background: There are only little data available on the comparison of clinical outcomes between a 1-stent strategy (1-SS) and a 2-stent strategy (2-SS) for percutaneous coronary intervention in unprotected distal left main disease.

08 noviembre 2016

CIRCULATION: CARDIOVASCULAR INTERVENTIONS. Incidence and Determinants of Complications in Rotational Atherectomy. Insights From the National Clinical Data (J-PCI Registry)

Kenichi Sakakura, Taku Inohara, Shun Kohsaka, Tetsuya Amano, Shiro Uemura, Hideki Ishii, Kazushige Kadota, Masato Nakamura, Hiroshi Funayama, Hideo Fujita, Shin-ichi Momomura

Background: The usage of rotational atherectomy (RA) is growing in the current percutaneous coronary intervention (PCI) because of the expansion of PCI indication to more complex lesions. However, the complications after RA have been linked to procedure-related morbidity and mortality. The purpose of this study was to investigate the incidence and determinants of complications in RA using a large nationwide registration system in Japan (J-PCI).

01 octubre 2015

JACC: CARDIOVASCULAR INTERVENTIONS. Percutaneous Transcatheter Assessment of the Left Main Coronary Artery. Current Status and Future Directions

Rong Bing, Andy S.C. Yong, Harry C. Lowe

Abstract: Accurate assessment of the left main coronary artery (LMCA) is critical in determining treatment strategies and delineating revascularization options to improve prognosis. There has been an evolution in invasive techniques that allow detailed assessment of both function and anatomy. As technologies advance, there is an increasing amount of evidence supporting the use of percutaneous coronary intervention for the LMCA. This state-of-the-art paper provides an in-depth exploration of intravascular ultrasound, fractional flow reserve, and optical coherence tomography. A discussion is provided that explores the basis for application of these technologies, the body of evidence for each modality and its use in LMCA assessment, and the potential role in post-PCI optimization in what is a dynamically changing field.

01 octubre 2015

JACC: CARDIOVASCULAR INTERVENTIONS. A Clinical and Angiographic Scoring System to Predict the Probability of Successful First-Attempt Percutaneous Coronary Intervention in Patients With Total Chronic Coronary Occlusion

Giuseppe Alessandrino, Bernard Chevalier, Thierry Lefèvre, Francesca Sanguineti, Philippe Garot, Thierry Unterseeh, Thomas Hovasse, Marie-Claude Morice, Yves Louvard

Objectives: This study sought to develop a scoring model predicting percutaneous coronary intervention (PCI) success in chronic total occlusions.

07 noviembre 2016

CIRCULATION. Where Is the Culprit Lesion?

Antoni Bayés de Luna and Miguel Fiol-Sala

A 67-year-old man who had experienced a previous heart attack 6 years ago now presents with severe constrictive chest pain for >2 hours with profuse sweating and low blood pressure. An ECG is recorded (Figure 1), and immediately after, the cardiac catheterization laboratory is activated. No prior ECGs are available. What is the diagnosis and what is the precise anatomic lesion?

29 agosto 2016

CIRCULATION. Ten-Year Outcomes After Coronary Artery Bypass Grafting According to Age in Patients With Heart Failure and Left Ventricular Systolic Dysfunction. An Analysis of the Extended Follow-Up of the STICH Trial (Surgical Treatment for Ischemic Heart Failure)

Mark C. Petrie, Pardeep S. Jhund, Lilin She, Christopher Adlbrecht, Torsten Doenst, Julio A. Panza, James A. Hill, Kerry L. Lee, Jean L. Rouleau, David L. Prior, Imtiaz S. Ali, Jyotsna Maddury, Krzysztof S. Golba, Harvey D. White, Peter Carson, Lukasz Chrzanowski, Alexander Romanov, Alan B. Miller and Eric J. Velazquez and On behalf of the STICH Trial Investigators

Background: Advancing age is associated with a greater prevalence of coronary artery disease in heart failure with reduced ejection fraction and with a higher risk of complications after coronary artery bypass grafting (CABG). Whether the efficacy of CABG compared with medical therapy (MED) in patients with heart failure caused by ischemic cardiomyopathy is the same in patients of different ages is unknown.

30 agosto 2016

CIRCULATION. Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study

Charles D. Resor, Ashwin Nathan, Dean J. Kereiakes, Robert W. Yeh, Joseph M. Massaro, Donald E. Cutlip, P. Gabriel Steg, Wen-Hua Hsieh and Laura Mauri and On behalf of the Dual Antiplatelet Therapy Study Investigators

Background: Continued dual antiplatelet therapy and optimal medical therapy (OMT) improve outcomes in selected patient populations with established coronary heart disease, but whether OMT modifies the treatment effect of dual antiplatelet therapy is unknown.

29 agosto 2016

CIRCULATION. Optical Coherence Tomography to Optimize Results of Percutaneous Coronary Intervention in Patients with Non–ST-Elevation Acute Coronary Syndrome. Results of the Multicenter, Randomized DOCTORS Study (Does Optical Coherence Tomography Optimize Results of Stenting)

Nicolas Meneveau, Geraud Souteyrand, Pascal Motreff, Christophe Caussin, Nicolas Amabile, Patrick Ohlmann, Olivier Morel, Yoann Lefrançois, Vincent Descotes-Genon, Johanne Silvain, Nassim Braik, Romain Chopard, Marion Chatot, Fiona Ecarnot, Hélène Tauzin, Eric Van Belle, Loïc Belle and François Schiele

Background: No randomized study has investigated the value of optical coherence tomography (OCT) in optimizing the results of percutaneous coronary intervention (PCI) for non–ST-segment elevation acute coronary syndromes.

29 agosto 2016

CIRCULATION. Optical Coherence Tomography Guidance for Percutaneous Intervention. The French “Doctors” Are Seeing Light at the End of the Tunnel

William Wijns and Stylianos A. Pyxaras

Adoption of invasive imaging for guidance during percutaneous coronary interventions (PCI) varies largely between clinical sites and between geographies, being greatest in Japan, intermediate to low in the United States and Asia, and very low to nonexistent in Europe. Yet nearly every interventional cardiologist will agree that intracoronary images obtained by intravascular ultrasound (IVUS) and optical coherence tomography (OCT) add significant information content to what is provided by angiography alone, thereby improving the understanding of and our capacity to interpret angiographic images. Although Japanese colleagues have the opportunity to use either IVUS or OCT in the majority of cases as part of their regular procedural strategy, use of invasive imaging in the rest of the world is hampered by inadequate or restricted reimbursement.

30 agosto 2016

CIRCULATION. Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction. Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54)

Marc P. Bonaca, Shinya Goto, Deepak L. Bhatt, P. Gabriel Steg, Robert F. Storey, Marc Cohen, Erica Goodrich, Laura Mauri, Ton Oude Ophuis, Mikhail Ruda, Jindřich Špinar, Ki-Bae Seung, Dayi Hu, Anthony J. Dalby, Eva Jensen, Peter Held, David A. Morrow, Eugene Braunwald and Marc S. Sabatine

Background: In the PEGASUS-TIMI 54 trial (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54), ticagrelor reduced the risk of major adverse cardiovascular events when added to low-dose aspirin in stable patients with prior myocardial infarction, resulting in the approval of ticagrelor 60 mg twice daily for long-term secondary prevention. We investigated the incidence of stroke, outcomes after stroke, and the efficacy of ticagrelor focusing on the approved 60 mg twice daily dose for reducing stroke in this population.

19 octubre 2015

CIRCULATION. When a Thrombus Is Life-Saving

Abdalla Elagha and Azza Farrag

A 37-year-old previously healthy man, a manual sugarcane juicer who lives in a rural area, presented with a 1-month history of atypical chest pain in his left shoulder area and a 2-week history of breathlessness on moderate exertion. On admission, the patient was tachycardic and tachypneic and had a blood pressure of 90/60 mm Hg with pulsus paradoxus. Physical examination showed elevated jugular venous pressure and distant heart sounds. ECG revealed ST-segment elevation in the anterior precordial leads (Figure 1A), but his troponin level was normal.

05 agosto 2015

CIRCULATION. Intramural Ventricular Septal Defect Is a Distinct Clinical Entity Associated With Postoperative Morbidity in Children After Repair of Conotruncal Anomalies

Jyoti K. Patel, Andrew C. Glatz, Reena M. Ghosh, Shannon M. Jones, Shobha Natarajan, Chitra Ravishankar, Christopher E. Mascio, Thomas L. Spray and Meryl S. Cohen

Background: Intramural ventricular septal defects (VSDs) are interventricular communications through right ventricular free wall trabeculations that can occur after repair of conotruncal anomalies. We assessed the prevalence of residual intramural VSDs and their effect on postoperative course.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.